Dergiler / International Journal of Medical Biochemistry / 2018 / Cilt: 1 - Sayı: 1

Relationship between glycemic control and serum uric acid level in acute myocardial infarction

Sayfa
11–14
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Additional studies should be done in order to make a definite decision about a potential relationship between glycemic control and SUA level in AMI.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: There are few studies on the relationship between glycemic control and the serum uric acid (SUA) level in acute myocardial infarction (AMI).
📊
Temel Bulgular & Veri:Sadi Konuk Education and Research Hospital between January 2017 and April 2017.
💡
Sonuç & Katkı:Conclusion: Additional studies should be done in order to make a definite decision about a potential relationship between glycemic control and SUA level in AMI.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: There are few studies on the relationship between glycemic control and the serum uric acid (SUA) level in acute myocardial infarction (AMI). The aim of this study was to investigate the relationship between glycemic control and SUA level in AMI. Methods: This was a retrospective study of patients with AMI who were in the coronary intensive care unit at Bakirkoy Dr. Sadi Konuk Education and Research Hospital between January 2017 and April 2017. Only patients with AMI were included. Age and sex data, as well as total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-c), lowdensity lipoprotein cholesterol (LDL-c), glucose, SUA, and glycated hemoglobin (HbA1c) results were obtained for the study. Patients were classified into 3 groups according to the presence and glycemic control status of diabetes mellitus. Group 1 comprised non-diabetic AMI patients (n=62) and was evaluated as control group. Diabetic patients with good or moderate glycemic control were included in Group 2 (n=35) (<8% HbA1c) and those with poor glycemic control (n=32) (≥8% HbA1c) composed Group 3. Results: The mean age of the study group was 61 years (SD: 13)(min: 34; max: 92 years). There was no statistically significant difference between groups with regard to the distribution of gender characteristics or the mean values of age, total cholesterol, or LDL-c. In addition, no statistically significant difference was found between the values for HDL-c, triglycerides, and SUA between the study groups. There was no statistically significant difference between the SUA level and the HbA1c level between groups. Conclusion: Additional studies should be done in order to make a definite decision about a potential relationship between glycemic control and SUA level in AMI.

🔖

Bu Makaleye Atıf Yap

CİRAKLİ, Z. L., NEIJMANN, S. T., KURAL, A., IŞIKSAÇAN, N., GEDİKBAŞI, A., ERDİN, S. (2018). Relationship between glycemic control and serum uric acid level in acute myocardial infarction. International Journal of Medical Biochemistry, Cilt: 1 - Sayı: 1, 11–14. https://ajindex.com/articles/162398

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Boateng S, Sanborn T. Acute myocardial infarction. Dis Mon 2013;59:83–96
  2. Krleza JL. Can glycated albumin assist in management of diabetes mellitus? Biochemia Medica 2014;24:S47–S52
  3. Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K. Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 2001;14:475–86
  4. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134–46
  5. Wilson PW. Diabetes mellitus and coronary heart disease. Am J Kidney Dis 1998;32:S89–100
  6. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140–4
  7. Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, et al; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications 2003;17:314–22
  8. Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) 2012;17:656–69
  9. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546–51
  10. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004;94:932–5
  11. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997;78:147–53
  12. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971- 1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404–10
  13. Meisinger C, Koenig W, Baumert J, Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008;28:1186–92
  14. De Scheerder IK, van de Kraay AM, Lamers JM, Koster JF, de Jong JW, Serruys PW. Myocardial malondia